Publications by authors named "Michael D Ezekowitz"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

179,868

Total Likes

297

Extended Reach

1,431,139

Social Features

210
2
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Socie
Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie

Circulation· July 2019

Videos about Article: user user user 1

4 14 196 6 90 3

View All Article and Social Media Activity
G
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Walter N Kernan, Bruce Ovbiagele, Henry R Black, Dawn M Bravata, Marc I Chimowitz, Michael D Ezekowitz, Margaret C Fang, Marc Fisher, Karen L Furie, Donald V Heck

Stroke· July 2014

Videos about Article: user user user

3 1 26 6 16

View All Article and Social Media Activity
T
The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.
Michael D Ezekowitz, Ibrahim Alameh, Mohammed Kamareddine

JACC Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
Linda S Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema, Michael D Ezekowitz

Eur Heart J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.
Sachin J Shah, Carl van Walraven, Sun Young Jeon, John Boscardin, F D Richard Hobbs, Michael D Ezekowitz

Circ Cardiovasc Qual Outcomes· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filling an Important Knowledge Gap: The DOAC Score.
Michael D Ezekowitz, Mohammed Kamareddine

Circulation· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant.
Roy Taoutel, Michael D Ezekowitz, Usman A Chaudhry, Carly Weber, Dana Hassan

Int J Cardiol Heart Vasc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation.
Matthew A Carlisle, Peter Shrader, Marat Fudim, Karen S Pieper, Rosalia G Blanco, Michael D Ezekowitz

Heart Rhythm O2· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
Tymon Pol, Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, John H Alexander, Michael D Ezekowitz

Cardiovasc Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Interactions Affecting Oral Anticoagulant Use.
Philip L Mar, Rakesh Gopinathannair, Brooke E Gengler, Mina K Chung, Arturo Perez, Michael D Ezekowitz

Circ Arrhythm Electrophysiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic.
Hans H Liu, Michael D Ezekowitz, Michele Columbo, Oneib Khan, Jack Martin

J Interv Card Electrophysiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
Alexander P Benz, Jeff S Healey, Ashley Chin, Patrick Commerford, Tamara Marsden, Michael D Ezekowitz

Cardiovasc Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Riccardo Cappato, Michael D Ezekowitz, Stefan H Hohnloser, Isabelle Ling Meng, Melanie Wosnitza

Europace· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.
Hans H Liu, Michael D Ezekowitz, Michele Columbo, Oneib Khan, Jack Martin

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial Fibrillation.
Usman A Chaudhry, Michael D Ezekowitz, Edward J Gracely, Winson T George, Catrina M Wolfe

Am J Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of oral anticoagulation use with cardioversion in clinical practice.
Kyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, Karen Pieper, Gregg Fonarow

Heart· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
Tymon Pol, Ziad Hijazi, Johan Lindbäck, John H Alexander, M Cecilia Bahit, Michael D Ezekowitz

Open Heart· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H Alexander, Stuart J Connolly, Michael D Ezekowitz

J Am Heart Assoc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
Lars Wallentin, Johan Lindbäck, Niclas Eriksson, Ziad Hijazi, John W Eikelboom, Michael D Ezekowitz

Eur Heart J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions.
Fatima Ali-Ahmed, Karen Pieper, Rebecca North, Larry A Allen, Paul S Chan, Michael D Ezekowitz

Eur Heart J Qual Care Clin Outcomes· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
Julia Aulin, Ziad Hijazi, Agneta Siegbahn, Ulrika Andersson, John H Alexander, Michael D Ezekowitz

J Thromb Haemost· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John H Alexander, Marco Alings, Michael D Ezekowitz

JAMA Netw Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.
Mariëlle Kloosterman, Jonas Oldgren, David Conen, Jorge A Wong, Stuart J Connolly, Michael D Ezekowitz

Europace· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
Benjamin A Steinberg, DaJuanicia N Holmes, Karen Pieper, Larry A Allen, Paul S Chan, Michael D Ezekowitz

Circ Arrhythm Electrophysiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Ventricular Thrombi: Uncommon But Clinically Important.
Michael D Ezekowitz, Daniel Kurz, Anthony Kent

J Am Coll Cardiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.
Taku Inohara, DaJuanicia N Holmes, Karen Pieper, Rosalia G Blanco, Larry A Allen, Michael D Ezekowitz

Heart· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial.
Paulus Kirchhof, Michael D Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L Meng

TH Open· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis